Kidney Damage Alert: CDSCO Issues Warning Against Excessive Painkillers & Antibiotics
_246515011.jpg)
India’s apex national drug regulatory authority, the Central Drugs Standard Control Organisation (CDSCO), has sounded a serious clinical alert regarding the widespread self-medication and overconsumption of over-the-counter painkillers and broad-spectrum antibiotics. In a comprehensive public circular, the drug controller highlighted that unmonitored, repeated, and prolonged ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) without certified medical supervision poses severe risks of acute renal impairment and irreversible kidney damage. Underlining statutory provisions under the Drugs and Cosmetics Rules, the national regulator mandated that both NSAIDs and antibiotic formulations are strictly classified as prescription drugs, requiring precise clinical evaluation regarding therapeutic necessity, dosage ceiling, and duration before administration.
Strict Medical Supervision: Why NSAIDs and Antibiotics Must Not Be Self-Administered
The CDSCO advisory outlines explicit protocols intended to curb the culture of habitual self-medication across households:
Strict Prescription Mandate: The regulatory framework under the Drugs and Cosmetics Rules designates analgesics, NSAIDs, and antibiotic therapies as Schedule prescription medicines, meaning they must never be procured or taken casually without a formal clinical assessment.
Avoid Habitual and Long-Term Use: Patients experiencing recurring headaches, body aches, joint stiffness, or mild fever are urged to refrain from continuously popping pain relief tablets over weeks, as unchecked usage accumulates systemic toxins in renal tissues.
Caution for High-Risk Groups: Individuals diagnosed with pre-existing renal conditions, high blood pressure, diabetes, or a family history of kidney failure are explicitly instructed to disclose their complete medical history to doctors prior to taking any anti-inflammatory or pain-relieving compounds.
AIIMS Expert Warning: Accelerated Renal Decline and India's Growing CKD Crisis
Medical specialists have strongly reinforced the drug regulator’s caution, pointing to escalating clinical data on kidney morbidity:
Nephrologist Insights from AIIMS: Highlighting the physiological mechanism of damage, AIIMS Department of Nephrology Professor Dr. Sandeep Mahajan noted that unregulated, sustained painkiller consumption constricts blood vessels inside the nephrons, drastically reducing blood filtration rates and accelerating chronic decline in overall kidney function.
Lowest Effective Dose Rule: The regulatory directive urges medical practitioners and pharmacists to adopt a conservative approach by prescribing only the lowest effective therapeutic dose for the shortest possible duration, while maintaining heightened vigilance for vulnerable kidney patients.
The Looming Chronic Kidney Disease Burden: This urgent national intervention comes against the backdrop of India's escalating chronic kidney disease (CKD) burden, with a 2025 review of community-based epidemiological studies estimating the nationwide CKD prevalence at 13.24%, emphasizing an urgent need to stop preventable drug-induced renal failure.
_1656967548_351x234.jpg)
_1076976861_351x234.jpg)
_703333760_351x234.jpg)
_1862704384_351x234.jpg)
_762061950_351x234.jpg)